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IMPORTANCE The genetic variant MYBPC3
Δ25bp occurs in 4% of South Asian descendants, with an estimated 100 million carriers worldwide. MYBPC3 Δ25bp has been linked to cardiomyopathy and heart failure. However, the high prevalence of MYBPC3 Δ25bp suggests that other stressors act in concert with MYBPC3
Δ25bp
.
OBJECTIVE To determine whether there are additional genetic factors that contribute to the cardiomyopathic expression of MYBPC3 Δ25bp .
DESIGN, SETTING, ANDPARTICIPANTS South Asian individuals living in the United States were screened for MYBPC3

Δ25bp
, and a subgroup was clinically evaluated using electrocardiograms and echocardiograms at Loyola University, Chicago, Illinois, between January 2015 and July 2016.
MAIN OUTCOMES AND MEASURES
Next-generation sequencing of 174 cardiovascular disease genes was applied to identify additional modifying gene mutations and correlate genotype-phenotype parameters. Cardiomyocytes derived from human-induced pluripotent stem cells were established and examined to assess the role of MYBPC3
Δ25bp
. RESULTS In this genotype-phenotype study, individuals of South Asian descent living in the United States from both sexes (36.23% female) with a mean population age of 48.92 years (range, 18-84 years) were recruited. 
Sample Collection and Genotyping
Participants were prospectively recruited and enrolled through community engagement at local venues. Saliva samples (3-5 mL) were collected in either sterile 15-mL tubes and frozen at −20°C or using the Saliva DNA Sample Collection Kit (Cat OG-500, DNA Genotek) and stored at ambient temperature. Blood samples for genotyping were collected in EDTA vacutainers (Catalog No. 367861; BD Bioscience), and DNA was isolated using the Blood DNA Isolation Kit (Catalog No. 51104; Qiagen). Polymerase chain reaction amplification of MYBPC3 Δ25bp (rs36212066) used the forward primer 5′-GTT TCC AGC CTT GGG CATAGT C-3′ and reverse primer 5′-GAG GAC AAC GGA GCA AAG CCC-3′, using REDTaq PCR master mix (Sigma-Aldrich) and 2.5% agarose gel analysis. DNA samples for sequencing were isolated from 10 mL of peripheral blood, as described previously, using the Blood DNA Isolation Kit (Catalog No. 51104; Qiagen). Participants in the United States who were positive for the MYBPC3 Δ25bp variant, their firstdegree relatives, or random control individuals were contacted in a single-blinded manner to participate in the follow-up genotype-phenotype study at Loyola University Chicago (LU207377 and LU207813), for which they provided additional written informed consent. Participants were provided a questionnaire pertaining to ethnic background, health history, family history, comorbid conditions, and current medications. The questionnaire was completed on a voluntary basis, and questions were answered only to the extent that each participant was willing.
Measuring Cardiac Function in US South Asian Individuals
Twelve-lead electrocardiograms with rhythm strips were performed at rest in a supine position using a MAC 5500 HD (GE Healthcare). Δ25bp was found in 6% of 2401 South Asian individuals living in the United States, and genetic and phenotypic characterization of a subset identified distinct populations within this heterogeneous group. Specifically, 9.6% of MYBPC3 Δ25bp carriers also had a novel MYBPC3 variant, D389V, on the same single allele, and this subset had hyperdynamic findings on echocardiogram.
Meaning Additional genetic variants, specifically D389V, were associated with the variable cardiomyopathic findings linked to MYBPC3
Δ25bp
. fractional shortening (LVFS) were calculated using Biplane Simpson method. Left ventricular diastolic function was evaluated using tissue Doppler velocities of mitral annulus as well as transmitral pulsed wave Doppler velocities. Medial and lateral tissue Doppler (e′) velocities were measured by placing the sample volume at the base of the interventricular septum and anterolateral wall in apical 4-chamber view immediately below the mitral annulus. Transmitral Doppler tracings were obtained by placing the sample volume in the left ventricle at the tip of the mitral valve leaflets. Early (E-wave) and late (A-wave) diastolic transmitral velocities, E to A ratio, and deceleration time were measured from transmitral Doppler tracings. Apical 4-chamber and 2-chamber views were used to determine left atrial area and length.
DNA Sequence Analysis
The TruSight Cardio Kit (Catalog No. FC-141-1011; Illumina) was used to sequence 174 cardiovascular disease genes (eTable 1 in the Supplement) on an Illumina MiSeq with 150-base pair paired-end reads. Sequences were aligned using the BurrowsWheeler Aligner, and the GATK haplotype caller was applied to generate variant call files as described. 16 Variants were in- participant, followed by Tukey multiple comparisons test. Statistical analyses were performed using Prism 7 (GraphPad).
Generation of Human-Induced Pluripotent Stem Cells and Cardiomyocyte Differentiation
Genotype-positive and genotype-negative participants were recruited to generate induced pluripotent stem cells (iPSCs). Peripheral blood mononuclear cells were isolated from whole blood (5 mL) using Ficoll-Paque (GE Healthcare Life Sciences) and cultured in peripheral blood mononuclear cell medium. Peripheral blood mononuclear cells were transduced using CytoTune-iPS 2.0 Sendai Reprogramming Kit (Thermo Fisher Scientific), all performed according to the manufacturers' instructions. Colonies that appeared underwent clonal expansion and were maintained in feeder-free conditions. 19 Human iPSCs were differentiated into cardiomyocytes using an embryoid body-based protocol. 20 Briefly, iPSCs were dissociated into single cells and aggregated into embryoid bodies with stage-specific media changes for the next 8 days. Embryoid bodies were plated on gelatin-coated dishes on day 8 and maintained in embryoid body-2 medium (Dulbecco modified eagle medium/F12 with 2% fetal bovine serum).
Imaging and Protein Analysis of Ca 2+ Transients
Imaging of Ca 2+ transients was performed on isolated single
CMs generated from human iPSCs and seeded on matrixcoated slides using the Ca 2+ probe fluo-4-acetoxymethyl ester (Fluo-4AM). Signals were captured using a high frame rate Cascade EMCCD camera (Photometrics) and analyzed using MetaMorph software, version 7 (Molecular Devices).
Statistical Analysis
Results were reported as mean (SE) of independent experiments. The comparison between 2 groups was performed using the t test, whereas to compare multiple groups, 1-way analysis of variance followed by Kruskal-Wallis analysis was used. A 2-sided P value less than .05 was considered statistically significant.
Results
Prevalence of MYBPC3 Δ25bp US South Asian Individuals
Most HCM-causing MYBPC3 mutations are dominantly inherited; however, MYBPC3 Δ25bp has a more complex effect because its population prevalence significantly exceeds that of HCM. 8, 9 We randomly screened for the presence of
MYBPC3
Δ25bp among US South Asian individuals. During a 2-year period, we evaluated 2401 US South Asian participants from several cities in the United States. Using a polymerase chain reaction-based assay (eFigure 1A in the Supplement), the population frequency of the MYBPC3 Δ25bp variant in US South Asian individuals was 6%, including both heterozygous (5.79%) and homozygous (0.21%) carriers (139 of 2401 and 5 of 2401, respectively) ( Figure 1 ), as measured from a diverse age group (eFigure 1B in the Supplement). These values are higher than the previously reported prevalence of approximately 4.0% in South Asian individuals. 9 The variant allele frequency was 3.14% with a Fisher exact test P value of .03, indicating that the variant's distribution follows HardyWeinberg equilibrium. (eTables 2-3 in the Supplement). We separately considered protein-altering variants in TTN, which encodes the giant protein titin. TTN truncating mutations are linked to heart failure and cardiomyopathy.
21,22 TTN is also uniquely enriched with an extraordinarily high degree of missense variants of unclear functional impact. We reasoned that the signature of TTN variation could be used to identify subgroups within the cohort of MYBPC3 Δ25bp carriers.
Δ25bp carriers had an excess of rare TTN variants (3.2 We found a novel MYBPC3 missense single-nucleotide polymorphism in a subset of MYBPC3 Δ25bp carriers encoding an A to T nucleotide change at chr11:47365100, producing a missense aspartic acid (D) to valine (V) variant at amino acid 389 in cMyBP-C (D389V) (Figure 2A and eFigure 3A in the Supplement). D389V was the only variant found to be significantly enriched in MYBPC3 Δ25bp carriers and was not identified in noncarriers (Fisher exact test 0.0019, eTable 4 in the Supplement). D389V localizes in MYBPC3 exon 12 at the interface between C2 domain of the cMyBP-C and the S2 domain of myosin ( Figure 2B and eFigure 3B in the Supplement). This domain interface directly regulates the superrelaxed state of cardiac contraction. 24 The glutamic acid in position 389 of the protein has been conserved among various species (eFigure 3C in the Supplement). We next screened specifically for the D389V variant and determined its presence in 13 of 136 MYBPC3 Δ25bp carriers (9.6%) and absence in 1488 US South Asian individuals who do not carry the MYBPC3 Δ25 allele ( Figure 3A) . D389V variant was carried in tandem on the same allele as MYBPC3
Δ25bp
, as confirmed by family studies (eFigure 4A in the Supplement). D389V variant was never seen in the absence of MYBPC3 , we examined human cardiomyocytes derived from iPSCs. Strikingly, cardiomyocytes derived from 2 individuals with MYBPC3 Δ25bp/D389V were significantly more hypertrophic compared with control cardiomyocytes and cardiomyocytes with MYBPC3 Δ25bp alone ( Figure 4A and B MYBPC3 variants have been described in combination with other genetic variants in the setting of dilated cardiomyopathy and heart failure, consistent with an oligogenic model of disease. 27-30 However, distinct from these previous studies, D389V and MYBPC3 Δ25bp are found together on the same single allele, and D389V was never observed in the absence of MYBPC3
. D389V maps near the beginning of immunoglobulin-like domain C2 in cMyBP-C protein, a region that is known to directly interact with the neck region of β-myosin heavy chain (S2-region), effectively regulating the engagement and interaction of myosin heads with actin filaments. 31 In silico tools predict D389V to be highly disruptive to protein function owing to the exchange of the highly conserved charged amino acid for a nonpolar moiety.
Limitations
This study specifically focused on 48 genes, mutations in which are known to cause cardiomyopathy. Systematic analysis of the additional sequenced genes could yield other cosegregating gene variations. The sample size in this study is relatively small, Rationale for exclusion of subjects from analysis: determined to have presence of mutations in genes known to cause cardiomyopathy, determined to have abnormally deviated echocardiographic parameters, or determined to have known prior cardiovascular disease.
